Neostigmine Methylsulfate Injection
Function and Efficacy
This product exerts a complete cholinergic effect by inhibiting the activity of cholinesterase. In addition, it can directly stimulate the nicotinic receptors (N2 receptors) on the motor end plates of skeletal muscles. Its action characteristics are weak effects on glandular, eye, cardiovascular and bronchial smooth muscles. It can promote gastric contraction and increase gastric acid secretion on gastrointestinal smooth muscles, and promote peristalsis of small and large intestines, especially the colon, thereby preventing intestinal relaxation and promoting the downward movement of intestinal contents. This product has a strong excitatory effect on skeletal muscles, but a weak effect on the central nervous system.
Ingredients
The main ingredient of this product is neostigmine methylsulfate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Neostigmine Methyl SulfateIngredients |
It exerts a complete cholinergic effect by inhibiting the activity of cholinesterase, can directly stimulate the nicotinic receptors (N2 receptors) on the motor end plates of skeletal muscles, promote gastric contraction and increase gastric acid secretion on gastrointestinal smooth muscles, and promote small and large intestine peristalsis, especially colon peristalsis, prevent intestinal relaxation, and promote the downward movement of intestinal contents. It has a strong excitatory effect on skeletal muscles, but a weak effect on glandular, eye, cardiovascular and bronchial smooth muscles, and a weak effect on the central nervous system. More |
51-60-5 | 31 |
Appearance
This product is a colorless clear liquid.
Indication
Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Usage and Dosage
1. Common dosage: 0.25-1 mg (1 ml: 0.5 mg half to 2 vials; 2 ml: 1 mg 1/4 to 1 vial) for subcutaneous or intramuscular injection, 1 to 3 times a day. 2. Maximum dosage: 1 mg (1 ml: 0.5 mg 2 vials; 2 ml: 1 mg 1 vial) for subcutaneous or intramuscular injection, 5 mg (1 ml: 0.5 mg 10 vials; 2 ml: 1 mg 5 vials) for daily use.
Adverse Reactions
This product can cause drug rash. Large doses can cause nausea, vomiting, diarrhea, tearing, salivation, etc. In severe cases, ataxia, convulsions, coma, slurred speech, anxiety, fear and even cardiac arrest may occur.
Precautions
1. It is contraindicated for people with allergic constitution. 2. It is contraindicated for patients with epilepsy, angina pectoris, ventricular tachycardia, mechanical intestinal obstruction or urinary tract obstruction and asthma. 3. It is contraindicated for patients with arrhythmia, sinus bradycardia, hypotension and increased vagal tone.
Special Population Medication
Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.
Drug Interactions
1. This product should not be used in combination with depolarizing muscle relaxants; 2. Certain drugs that can interfere with muscle transmission, such as quinidine, can weaken the effect of this product and should not be used in combination.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
2ml:1mg
Validity Period
24 months
Manufacturer
Jiangsu Pujin Pharmaceutical Co., Ltd.
-
Founded in:
2000-01-03 -
Address:
No. 65, Huaihe East Road, Xucheng Town, Xuyi County -
Tax NO.:
91320830703838125N -
Registered Funds:
30 million yuan -
Email: